News NHS U-turns on Afinitor for TSC-related epilepsy NHS England has reversed a previous decision and will be funding Novartis’ Afinitor (everolimus)
News GW launches cannabis-based epilepsy drug in US GW Pharmaceuticals is bullish about the company’s prospects following the launch of its cannabis-based medicine for a rare form of childhood epilepsy.
News GW Pharma's marijuana-based epilepsy drug approved in US The FDA has approved UK-based GW Pharmaceuticals' drug for a rare form of childhood epilepsy - the first marijuana-based medicine approved in the US.
News FDA advisers back GW's Epidiolex for rare epilepsy UK firm's potential blockbuster on course for approval
News GW files cannabis-based epilepsy drug in EU and US After Sativex disappointment, Epidiolex could transform GW's fortunes.
News RFK Jr revives childhood vaccine task force HHS Secretary Kennedy adds yet another layer of scrutiny to childhood vaccines with the re-establishment of a task force disbanded in the 1990s.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
